Activartis’ Cancer Immunotherapy Receives Orphan Drug Designation from FDA

News   Jul 01, 2013

 
Activartis’ Cancer Immunotherapy Receives Orphan Drug Designation from FDA
 
 
 

RELATED ARTICLES

Past Exposure Shapes Immune Responses in Pediatric Acute Respiratory Infections

News

By analyzing immune cells of children who came to the emergency department with flu symptoms, researchers found that the suite of genes these early-response cells expressed was shaped by factors such as age and previous exposures to viruses. Better understanding how early infections influence long-term immune response has implications for the diagnosis and treatment of young patients who suffer from acute respiratory tract infections.

READ MORE

Can Muesli Help Battle Arthritis?

News

It is well known that healthy eating increases our general sense of wellbeing. Researchers have now discovered that a fibre-rich diet can have a positive influence on chronic inflammatory joint diseases, leading to stronger bones.

READ MORE

Junk Food Has Lasting Effects on the Immune System

News

The immune system reacts similarly to a high fat and high calorie diet as to a bacterial infection. Scientists have shown that unhealthy food seems to make the body’s defences more aggressive in the long term. Even long after switching to a healthy diet, inflammation towards innate immune stimulation is more pronounced. These long-term changes may be involved in the development of arteriosclerosis and diabetes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE